Background
==========

Coxsackievirus RNA has recently been detected in biopsy specimens of minor salivary glands from patients with Sjögren\'s syndrome (SS). A peptide of 3C protease of Coxsackievirus (pepCoxs) has 87% homology with a major linear B-cell epitope of Ro60 protein spanning the sequence 216--232aa.

Objective
=========

To investigate a possible cross-reaction between Coxsackievirus 3C protease and Ro60 autoantigen.

Methods
=======

PepCoxs MVTSTITEKLLKNLVKI and pep216--232 of Ro60 KALSVETEKLLKYLEAV were prepared. Sera from 27 patients with SS and 28 patients with systemic lupus erythematosus (SLE) were tested against the two homologous peptides. Twenty-eight samples were a-Ro (+), and 26 samples were a-Ro/a-La (+). Sera from 27 healthy individuals were used as normal controls. Antibodies against Ro60 peptide were purified and tested for antipeptide reactivity.

Results
=======

Of SLE sera 25%, and 33.3% of SS sera reacted against pep216--232, whereas 28% of SLE sera and 37% of SS sera reacted against pepCoxs. The reactivity of normal sera against pep216--232 and pepCoxs was 17.4% and 3.7%, respectively. Pep216--232 was recognized by 17% of the a-Ro (+) sera and by 42% of the a-Ro/La (+) sera, whereas pepCoxs was recognized by 28.5% and 38% of the a-Ro (+) and a-Ro/La (+) sera, respectively. Both peptides reacted more prominently with a-Ro/La (+) sera from SS patients. Purified a-Ro60 antibodies reacted with both peptides and inhibition experiments revealed the specificity of this reaction.

Conclusion
==========

These results revealed a possible cross-reaction between the major linear B-cell epitope of Ro60 protein (216--232aa) and the homologous peptide of Coxsackie virus 3C-protease in SS patients. This cross-reaction might potentially play a role on autoantibody formation and pathogenesis of SS.
